A randomised placebo-controlled trial of low-dose transdermal estrogen in transgender women during surgery
Phase 4
- Conditions
- TransgenderGender affirmation surgeryThrombosisMetabolic and Endocrine - Other endocrine disordersBlood - Clotting disorders
- Registration Number
- ACTRN12621000022864
- Lead Sponsor
- niversity of Melbourne
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Transgender women undergoing gender affirmation surgery (vaginoplasty or labioplasty).
Exclusion Criteria
Contraindications to estradiol including estrogen-sensitive malignancy
History of thromboembolic disease
Known thrombophilia
Use of estradiol implant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method